[go: up one dir, main page]

TWI808364B - Adhesive and localizing hydrogel kit and the use thereof - Google Patents

Adhesive and localizing hydrogel kit and the use thereof Download PDF

Info

Publication number
TWI808364B
TWI808364B TW109144798A TW109144798A TWI808364B TW I808364 B TWI808364 B TW I808364B TW 109144798 A TW109144798 A TW 109144798A TW 109144798 A TW109144798 A TW 109144798A TW I808364 B TWI808364 B TW I808364B
Authority
TW
Taiwan
Prior art keywords
catechol
alginate
hydrogel
solution
positioning
Prior art date
Application number
TW109144798A
Other languages
Chinese (zh)
Other versions
TW202228780A (en
Inventor
陳晉興
陳克誠
紀又仁
蔡婷伃
周俞均
吳欣儒
楊台鴻
Original Assignee
國立臺灣大學
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 國立臺灣大學 filed Critical 國立臺灣大學
Priority to TW109144798A priority Critical patent/TWI808364B/en
Publication of TW202228780A publication Critical patent/TW202228780A/en
Application granted granted Critical
Publication of TWI808364B publication Critical patent/TWI808364B/en

Links

Landscapes

  • Materials For Medical Uses (AREA)
  • Thermotherapy And Cooling Therapy Devices (AREA)

Abstract

This application provides an adhesive and localizing hydrogel kit for localizing the affected area and/or filling up the lesion before surgery, comprising: catechol alginate solution with a concentration of 20 mg/mL and above, oxidant solution, and catalase; wherein the molar ratio of the oxidant to the catechol group of the catechol alginate is 0.1~2.2. In addition, the present application provides a use of catechol alginate hydrogel for preparing a hydrogel for localizing affected area and/or filling up the lesion, and the mixing device thereof.

Description

一種兼具定位及修補功能之水膠套組及其用途A water-glue set with both positioning and repairing functions and its application

本發明涉及一種兼具定位及修補功能之水膠套組,特別是鄰苯二酚–海藻酸鹽水膠用於肺癌手術前的腫瘤組織或惡性結節定位,該水膠同時具備填補氣胸的功能。The invention relates to a hydrogel set with both positioning and repairing functions, in particular, the catechol-alginate hydrogel is used for positioning tumor tissue or malignant nodules before lung cancer surgery, and the hydrogel also has the function of filling pneumothorax.

肺癌是世界上最常見且死亡率高的癌症之一,為降低肺癌死亡率,早期診斷非常重要。肺癌在初期階段大多呈現小型的惡性結節,可透過低劑量的CT (LDCT)來檢測出,但在開刀切除腫瘤時,因這些惡性結節體積小,難以透過肉眼或觸摸來確認位置,所以胸腔外科醫師在開刀切除前,會先請放射科醫師對病患肺部的惡性結節做定位,方法有植入帶鉤細金屬絲(hookwire),或是施打染劑(例如拍得藍(patent blue V))到病灶來協助定位。然而現今的定位手術方法,除了會引起病人氣胸之外,裸露在病人胸腔外的金屬絲也會引起病患的恐懼和不便,而水溶性的染劑也會在病患呼吸或是移動時擴散,造成定位不精確或失敗。因此我們研發出一種帶有黏性和顏色的水膠,注射進病患肺部後,能夠緊緊的黏在病灶處不擴散,並且堵住定位手術時因針頭插入肺所造成的破洞,降低氣胸發生的機率,用以提供醫病間一個新的定位材料之選擇。Lung cancer is one of the most common cancers with a high mortality rate in the world. To reduce the mortality rate of lung cancer, early diagnosis is very important. Lung cancer usually presents small malignant nodules in the early stages, which can be detected by low-dose CT (LDCT). However, during surgical resection, these malignant nodules are small in size and difficult to confirm the location with the naked eye or by touch. Therefore, before surgical resection, thoracic surgeons will first ask radiologists to locate the malignant nodules in the patient's lungs. Methods include implanting a thin hookwire (hookwire) or applying dye (such as patent blue V) to the patient's lungs. stove to assist in positioning. However, in today’s positioning surgery methods, in addition to causing pneumothorax, the metal wires exposed outside the patient’s chest will also cause fear and inconvenience to the patient, and the water-soluble dye will also spread when the patient breathes or moves, resulting in inaccurate positioning or failure. Therefore, we have developed a kind of viscous and colored water glue. After injection into the patient's lungs, it can tightly stick to the lesion without spreading, and block the hole caused by the needle inserted into the lung during positioning surgery, reducing the probability of pneumothorax. It is used to provide a new choice of positioning materials between doctors and patients.

近年研究發現,貽貝類的觸手在含水的環境下,依然能黏附在各種材料表面上,其因源自於牠的觸手能夠分泌出含大量鄰苯二酚(catechol)的黏液,鄰苯二酚的結構能與無機、有機物表面形成共價鍵和非共價鍵,進而產生黏性。In recent years, studies have found that the tentacles of mussels can still adhere to the surface of various materials in a water-containing environment. The reason is that its tentacles can secrete mucus containing a large amount of catechol. The structure of catechol can form covalent and non-covalent bonds with the surface of inorganic and organic substances, thereby producing stickiness.

自2012年以來,鄰苯二酚共軛海藻酸鹽(Catechol-conjugated alginate)已被合成並應用於多個醫學領域的研究中。C. J. Kastrup等人於「Painting blood vessels and atherosclerotic plaques with an adhesive drug depot」的論文中使用鄰苯二酚–海藻酸鹽(Catechol alginate)作為粘合劑,治療血管疾病。S. Zhang等人於「Mussel-inspired alginate gel promoting the osteogenic differentiation of mesenchymal stem cells and anti-infection」的論文中用相同的材料成功地促進了間質幹細胞的骨原分化。F. Scognamiglio於「Enhanced bioadhesivity of dopamine-functionalized polysaccharidic membranes for general surgery applications」的論文中通過混合鄰苯二酚–海藻酸鹽和透明質酸來製造薄膜,並藉由將該薄膜包裹吻合處以試圖減少腸吻合口滲漏(Bowel anastomotic leakage)。使用鄰苯二酚–海藻酸鹽作為粘合劑的想法也已被提出。Junxia Hou等人於「Enzymatically crosslinked alginate hydrogels with improved adhesion properties」的論文中用山葵過氧化酶(Horseradish peroxidase,HRP)和H 2O 2氧化鄰苯二酚–海藻酸鹽來製備原位粘合劑,其表明鄰苯二酚官能化的海藻酸鹽凝膠比酚官能化的海藻酸鹽和海藻酸鹽-酪胺水凝膠(Alg-TA)表現出顯著改善的粘合性能,然而,其達到膠凝點的時間太長,無法應用於所用的藥物,且該酶也太昂貴,不適合臨床應用。 Since 2012, Catechol-conjugated alginate has been synthesized and applied in research in several medical fields. CJ Kastrup et al. used catechol-alginate (Catechol alginate) as an adhesive in the paper "Painting blood vessels and atherosclerotic plaques with an adhesive drug depot" to treat vascular diseases. In the paper "Mussel-inspired alginate gel promoting the osteogenic differentiation of mesenchymal stem cells and anti-infection", S. Zhang et al. used the same material to successfully promote the osteogenic differentiation of mesenchymal stem cells. F. Scognamiglio in the paper "Enhanced bioadhesivity of dopamine-functionalized polysaccharides membranes for general surgery applications" made a film by mixing catechol-alginate and hyaluronic acid, and wrapped the film around the anastomosis to try to reduce Bowel anastomotic leakage. The idea of using catechol-alginate as a binder has also been proposed. In the paper "Enzymatically crosslinked alginate hydrogels with improved adhesion properties", Junxia Hou et al. used horseradish peroxidase (HRP) and H2O2 to oxidize catechol- alginate to prepare in situ adhesives, which showed that catechol-functionalized alginate gels were more effective than phenol-functionalized alginate and alginate-tyramine The hydrogel (Alg-TA) exhibited significantly improved adhesive properties, however, its time to reach the gel point was too long to be applicable to the drugs used, and the enzyme was too expensive to be suitable for clinical applications.

鑒於先前技術所存在之問題,本申請提供一種兼具定位及修補功能之水膠套組,用於手術前的患部定位及/或修補,包含: 鄰苯二酚–海藻酸鹽溶液,濃度20毫克/毫升(mg/mL)以上; 氧化劑溶液;及 過氧化氫酶; 其中,該氧化劑與該鄰苯二酚–海藻酸鹽中鄰苯二酚基的莫耳比為0.1 ~ 2.2。 In view of the problems existing in the prior art, this application provides a water glue set with both positioning and repairing functions, which is used for positioning and/or repairing the affected part before surgery, including: Catechol-alginate solution, concentration above 20 mg/mL (mg/mL); oxidant solution; and Catalase; Wherein, the molar ratio of the oxidant to the catechol group in the catechol-alginate is 0.1 to 2.2.

在一實施方式中,該氧化劑選自過碘酸鹽、碘酸鹽、纖維蛋白原、酪胺酸酶、山葵過氧化酶和過氧化氫所組成之群組。較佳的,該氧化劑過碘酸鈉。In one embodiment, the oxidizing agent is selected from the group consisting of periodate, iodate, fibrinogen, tyrosinase, horseradish peroxidase and hydrogen peroxide. Preferably, the oxidizing agent is sodium periodate.

在一實施方式中,該鄰苯二酚–海藻酸鹽溶液之濃度為35毫克/毫升(mg/mL)以上;該氧化劑與該鄰苯二酚–海藻酸鹽中鄰苯二酚基的莫耳比為0.2 ~ 0.8;該過氧化氫酶之濃度為600 IU/mL ~1000 IU/mL。In one embodiment, the concentration of the catechol-alginate solution is above 35 mg/mL; the molar ratio of the oxidant to the catechol group in the catechol-alginate is 0.2-0.8; the concentration of the catalase is 600 IU/mL-1000 IU/mL.

在一實施方式中,該鄰苯二酚–海藻酸鹽溶液之濃度為40毫克/毫升(mg/mL)以上,該氧化劑為過碘酸鈉,該氧化劑與該鄰苯二酚–海藻酸鹽中鄰苯二酚基的莫耳比為0.25 ~ 0.6,該過氧化氫酶之濃度為800 IU/mL。In one embodiment, the concentration of the catechol-alginate solution is above 40 mg/mL, the oxidant is sodium periodate, the molar ratio of the oxidant to the catechol group in the catechol-alginate is 0.25-0.6, and the concentration of the catalase is 800 IU/mL.

在一實施方式中,其中該兼具定位及修補功能之水膠套組更包含染劑、螢光染劑及/或顯影劑。In one embodiment, the hydrogel kit with both positioning and repairing functions further includes dyes, fluorescent dyes and/or developers.

在一實施方式中,所述兼具定位及修補功能之水膠套組更包含: 一第一注射器,包含該鄰苯二酚–海藻酸鹽溶液; 一第二注射器,包含該氧化劑溶液; 一多向閥; 其中,該第一注射器包含該過氧化氫酶。 In one embodiment, the water glue set with both positioning and repairing functions further includes: a first syringe containing the catechol-alginate solution; a second syringe containing the oxidizing agent solution; a multi-way valve; Wherein, the first syringe contains the catalase.

在一實施方式中,該多向閥為雙向閥或三向閥。In one embodiment, the multi-way valve is a two-way valve or a three-way valve.

另外,本申請更提供一種鄰苯二酚–海藻酸鹽、氧化劑及過氧化氫酶之組合,用於製備患部定位及修補水膠的用途。亦或,一種鄰苯二酚–海藻酸鹽水膠用於製備患部定位及修補水膠的用途。In addition, the present application further provides a combination of catechol-alginate, oxidizing agent and catalase for preparing water gel for positioning and repairing affected parts. Alternatively, a catechol-alginate hydrogel is used for preparing the affected part positioning and repairing hydrogel.

在一實施方式中,該患部為肺中的腫瘤組織或惡性結節。In one embodiment, the affected part is tumor tissue or malignant nodules in the lung.

綜上,本申請所提供之兼具定位及修補功能之水膠套組或用途,其係將擁有鄰苯二酚官能基的多巴胺(Dopamine),透過1-乙基-3-(3-二甲基氨基丙基)碳醯二亞胺(1-(3-Dimethylaminopropyl)-3-ethylcarbodiimide hydrochloride,EDC)及N-羥基琥珀醯亞胺(N-hydroxysuccinimide,NHS)反應接枝到具有高度生物相容性的海藻酸鈉(sodium alginate)上,形成鄰苯二酚–海藻酸鹽(catechol alginate)。在操作上,係將鄰苯二酚–海藻酸鹽、氧化劑(過碘酸鈉,NaIO 4)和過氧化氫酶混合,形成一種可注射式水膠。透過成膠時間、機械性質、爆破壓力以及定位效果的測試之後,確認我們研發的水膠具有適當黏性及明顯的成色,以利於應用在組織定位、修補肺部等臨床手術上。 To sum up, the water glue set or application provided by this application with both positioning and repairing functions is to use catechol functional group dopamine (Dopamine) through 1-(3-Dimethylaminopropyl)-3-ethylcarbodiimide hydrochloride (EDC) and N-hydroxysuccinimide (N-hy Droxysuccinimide (NHS) was grafted onto highly biocompatible sodium alginate to form catechol-alginate. In operation, catechol-alginate, oxidizing agent (sodium periodate, NaIO 4 ) and catalase are mixed to form an injectable hydrogel. Through the tests of gelation time, mechanical properties, burst pressure and positioning effect, it is confirmed that the water gel developed by us has appropriate viscosity and obvious color, so as to facilitate the application in clinical operations such as tissue positioning and lung repair.

本發明之優點及特徵以及達到其方法將參照例示性實施例及附圖進行更詳細地描述而更容易理解。然而,本發明可以不同形式來實現且不應該被理解僅限於此處所陳述的實施例。相反地,對所屬技術領域具有通常知識者而言,所提供的此些實施例將使本揭露更加透徹與全面且完整地傳達本發明的範疇,且本發明將僅為所附加的申請專利範圍所定義。如本文中所使用的,術語”及/或”包含任何及所有一或多相關所列物件的組合。The advantages and features of the present invention and methods for achieving them will be more easily understood by describing in more detail with reference to exemplary embodiments and accompanying drawings. However, the invention may be embodied in different forms and should not be construed as limited to the embodiments set forth herein. On the contrary, for those skilled in the art, these embodiments are provided to make this disclosure more thorough and comprehensive and fully convey the scope of the present invention, and the present invention will only be defined by the appended claims. As used herein, the term "and/or" includes any and all combinations of one or more of the associated listed items.

除非另外定義,所有使用於本文的術語(包含科技及科學術語)具有與本發明所屬該領域的技術人士一般所理解相同的意思。將更可理解的是,例如於一般所使用的字典所定義的那些術語應被理解為具有與相關領域的內容一致的意思,且除非明顯地定義於本文,將不以過度理想化或過度正式的意思理解。如本說明書所記載者,範圍數值係作為說明在該範圍內的各個及每一個數值的簡略表示,在該範圍內的任何數值可被選作為該範圍的端值。Unless otherwise defined, all terms (including technical and scientific terms) used herein have the same meaning as commonly understood by one of ordinary skill in the art to which this invention belongs. It will be more understandable that terms such as those defined in commonly used dictionaries should be understood as having meanings consistent with the contents of the relevant fields, and will not be understood in an overly idealized or overly formal meaning unless clearly defined herein. As stated herein, range values are intended to be shorthand for describing each and every value within the range, and any value within the range can be selected as an endpoint of the range.

本申請提供一種兼具定位及修補功能之水膠套組,用於手術前的患部定位及修補,包含: 鄰苯二酚–海藻酸鹽溶液,濃度20毫克/毫升(mg/mL)以上; 氧化劑溶液;及 過氧化氫酶; 其中,該氧化劑與該鄰苯二酚–海藻酸鹽中鄰苯二酚基的莫耳比為0.1 ~ 2.2。 This application provides a water gel set with both positioning and repairing functions, which is used for positioning and repairing the affected part before surgery, including: Catechol-alginate solution, concentration above 20 mg/mL (mg/mL); oxidant solution; and Catalase; Wherein, the molar ratio of the oxidant to the catechol group in the catechol-alginate is 0.1 to 2.2.

在一實施方式中,該氧化劑選自過碘酸鹽、碘酸鹽、纖維蛋白原、酪胺酸酶、山葵過氧化酶和過氧化氫所組成之群組。較佳的,該氧化劑過碘酸鈉。In one embodiment, the oxidizing agent is selected from the group consisting of periodate, iodate, fibrinogen, tyrosinase, horseradish peroxidase and hydrogen peroxide. Preferably, the oxidizing agent is sodium periodate.

在一實施方式中,該鄰苯二酚–海藻酸鹽溶液之濃度為35毫克/毫升(mg/mL)以上;該氧化劑與該鄰苯二酚–海藻酸鹽中鄰苯二酚基的莫耳比為0.2 ~ 0.8;該過氧化氫酶之濃度為600 IU/mL ~1000 IU/mL。In one embodiment, the concentration of the catechol-alginate solution is above 35 mg/mL; the molar ratio of the oxidant to the catechol group in the catechol-alginate is 0.2-0.8; the concentration of the catalase is 600 IU/mL-1000 IU/mL.

在一實施方式中,該鄰苯二酚–海藻酸鹽溶液之濃度為40毫克/毫升(mg/mL)以上,該氧化劑為過碘酸鈉,該氧化劑與該鄰苯二酚–海藻酸鹽中鄰苯二酚基的莫耳比為0.25 ~ 0.6,該過氧化氫酶之濃度為800 IU/mL。In one embodiment, the concentration of the catechol-alginate solution is above 40 mg/mL, the oxidant is sodium periodate, the molar ratio of the oxidant to the catechol group in the catechol-alginate is 0.25-0.6, and the concentration of the catalase is 800 IU/mL.

在一實施方式中,其中該兼具定位及修補功能之水膠套組更包含染劑、螢光染劑及/或顯影劑。In one embodiment, the hydrogel kit with both positioning and repairing functions further includes dyes, fluorescent dyes and/or developers.

在一實施方式中,所述兼具定位及修補功能之水膠套組更包含: 一第一注射器,包含該鄰苯二酚–海藻酸鹽溶液; 一第二注射器,包含該氧化劑溶液; 一多向閥; 其中,該第一注射器包含該過氧化氫酶。 In one embodiment, the water glue set with both positioning and repairing functions further includes: a first syringe containing the catechol-alginate solution; a second syringe containing the oxidizing agent solution; a multi-way valve; Wherein, the first syringe contains the catalase.

在一實施方式中,該多向閥為雙向閥或三向閥。In one embodiment, the multi-way valve is a two-way valve or a three-way valve.

另外,本申請更提供一種鄰苯二酚–海藻酸鹽、氧化劑及過氧化氫酶之組合,用於製備患部定位及修補水膠的用途。亦或,一種鄰苯二酚–海藻酸鹽水膠用於製備患部定位及修補水膠的用途。In addition, the present application further provides a combination of catechol-alginate, oxidizing agent and catalase for preparing water gel for positioning and repairing affected parts. Alternatively, a catechol-alginate hydrogel is used for preparing the affected part positioning and repairing hydrogel.

在一實施方式中,該患部為肺中的腫瘤組織或惡性結節。In one embodiment, the affected part is tumor tissue or malignant nodules in the lung.

以下列舉數個實施例作為例示,說明本申請之實施方式;熟習此技藝者可經由本說明書之內容輕易地了解本創作所能達成之優點與功效,並且於不悖離本創作之精神下進行各種修飾與變更,以施行或應用本創作之內容。Several examples are listed below as examples to illustrate the implementation of this application; those skilled in the art can easily understand the advantages and effects of this creation through the contents of this specification, and make various modifications and changes without departing from the spirit of this creation to implement or apply the content of this creation.

實施例1─鄰苯二酚–海藻酸鹽的製備Embodiment 1─catechol-preparation of alginate

將 0.5克中黏度的海藻酸鈉(Sodium Alginate,ALG)粉末和1.0克低黏度的ALG粉末溶於30毫升水中後,於室溫下通入氬氣去氧攪拌2~3小時後。接著,將EDC緩慢地加入ALG溶液中(莫耳比3:1),於室溫及pH 5~5.5環境下攪拌30分鐘,讓EDC充分活化ALG上的羧基。再來,將去氧處理過的多巴胺(Dopamine hydrochloride,DOPA)水溶液緩慢地加入經EDC活化後的ALG溶液中溶液中(莫耳比5:1),並攪拌約5~10分鐘。最後緩慢地將NHS水溶液加入ALG混合溶液中(EDC與NHS莫耳比為1:1)形成鄰苯二酚–海藻酸鹽(Catechol alginate,C-ALG)溶液。其反應如下所示: Dissolve 0.5 g of medium-viscosity sodium alginate (Sodium Alginate, ALG) powder and 1.0 g of low-viscosity ALG powder in 30 ml of water, then pass through argon gas at room temperature to deoxygenate and stir for 2-3 hours. Next, EDC was slowly added to the ALG solution (molar ratio 3:1), and stirred for 30 minutes at room temperature and pH 5-5.5 to allow EDC to fully activate the carboxyl groups on ALG. Next, slowly add deoxygenated dopamine hydrochloride (DOPA) aqueous solution into the EDC-activated ALG solution (molar ratio 5:1), and stir for about 5-10 minutes. Finally, the NHS aqueous solution was slowly added to the ALG mixed solution (the molar ratio of EDC to NHS was 1:1) to form a catechol-alginate (Catechol alginate, C-ALG) solution. Its response is as follows:

將C-ALG溶液以1 N的氫氧化鈉(Sodium Hydroxide,NaOH)水溶液調整C-ALG溶液之pH至9,此時C-ALG溶液應呈現棕紅色。持續通入氬氣反應至隔天,使接枝反應完全。反應完成後,將產物倒入99.5%甲醇中使之析出,重複此步驟3次以清洗掉未反應的DOPA。最後,減壓抽乾產物,以利長期保存之。Adjust the pH of the C-ALG solution to 9 with 1 N aqueous sodium hydroxide (Sodium Hydroxide, NaOH) solution, at this time the C-ALG solution should appear brownish red. The argon gas was continuously passed through to react until the next day, so that the grafting reaction was complete. After the reaction was completed, the product was poured into 99.5% methanol to precipitate it, and this step was repeated 3 times to wash away unreacted DOPA. Finally, the product was dried under reduced pressure for long-term storage.

實施例2─鄰苯二酚–海藻酸鹽水膠的形成Example 2 - Formation of catechol-alginate hydrogel

以pH 7.4磷酸鹽緩衝生理鹽水(phosphate buffer saline, PBS)將乾燥C-ALG回溶,並於每1 mL溶液中加入800 IU 過氧化氫酶。最後,將不同濃度之NaIO 4和C-ALG溶液以等體積(100 uL)滴入2 mL小瓶均勻混合,並於37℃環境下使其交聯形成水膠。通過小瓶傾斜測定法(vial tilting assay)測試交聯形成,並且將交聯時間定義為當小瓶傾斜時溶液失去流動性的時間。每個樣品進行3次交聯時間測試,如果交聯時間花費超過20分鐘,則認為失敗。如下表1所示: 表1:材料組成之比例及其交聯時間 C-ALG濃度 (mg/mL) NaIO 4濃度 (mg/mL) 莫耳比 (NaIO 4/鄰苯二酚基) 交聯時間(秒) 試驗編號 15 0.72 0.25 失敗 (>20分鐘) -- 1.44 0.5 失敗 (>20分鐘) -- 2.88 1 失敗 (>20分鐘) -- 5.76 2 失敗 (>20分鐘) -- 30 0.72 0.125 548.67  8.62 -- 1.44 0.25 178.7  6.0 CA-1 2.88 0.5 565  13.5 -- 5.76 1 失敗 (>20分鐘) -- 11.52 2 失敗 (>20分鐘) -- 40 0.96 0.125 313.67  9.7 -- 1.92 0.25 140.3  10.5 CA-2 3.84 0.5 122.7  7.5 CA-3 7.68 1 66.67  7.51 -- 15.36 2 701  19.3 -- The dried C-ALG was redissolved with pH 7.4 phosphate buffer saline (PBS), and 800 IU of catalase was added to each 1 mL solution. Finally, equal volumes (100 uL) of different concentrations of NaIO 4 and C-ALG solutions were dropped into a 2 mL vial and mixed evenly, and allowed to cross-link at 37°C to form a hydrogel. Crosslink formation was tested by vial tilting assay, and crosslink time was defined as the time for the solution to lose fluidity when the vial was tilted. Each sample was tested for crosslinking time 3 times and was considered a failure if the crosslinking time took more than 20 minutes. Table 1 below: Table 1: Ratio of material composition and crosslinking time C-ALG concentration (mg/mL) NaIO 4 concentration (mg/mL) Molar ratio (NaIO 4 /catechol base) Cross-linking time (seconds) Test No. 15 0.72 0.25 Failed (>20 minutes) -- 1.44 0.5 Failed (>20 minutes) -- 2.88 1 Failed (>20 minutes) -- 5.76 2 Failed (>20 minutes) -- 30 0.72 0.125 548.67 8.62 -- 1.44 0.25 178.7 6.0 CA-1 2.88 0.5 565 13.5 -- 5.76 1 Failed (>20 minutes) -- 11.52 2 Failed (>20 minutes) -- 40 0.96 0.125 313.67 9.7 -- 1.92 0.25 140.3 10.5 CA-2 3.84 0.5 122.7 7.5 CA-3 7.68 1 66.67 7.51 -- 15.36 2 701 19.3 --

交聯過程中水膠的顏色產生變化,成膠後的水膠呈深褐色,如圖1A所示。高濃度的C-ALG會導致較快的交聯形成,但是當氧化劑濃度過高時,交聯時間會變長,例如C-ALG濃度40 mg/mL且NaIO 4/鄰苯二酚基莫耳比為2的樣品,其交聯時間反而較長。當使用高濃度氧化劑時,C-ALG溶液與氧化劑的交聯反應也可能不均勻,例如C-ALG濃度40 mg/mL且NaIO 4/鄰苯二酚基莫耳比為1的樣品中,雖然其交聯時間短,但在高NaIO 4/鄰苯二酚基莫耳比的情況下,由於高反應速率,其交聯形成具有顆粒的不均勻水膠。 The color of the hydrocolloid changes during the crosslinking process, and the gelled hydrocolloid is dark brown, as shown in Figure 1A. A high concentration of C-ALG will lead to faster cross-linking, but when the concentration of the oxidant is too high, the cross-linking time will be longer. For example, the sample with a C-ALG concentration of 40 mg/mL and a NaIO 4 /catechol molar ratio of 2 has a longer cross-linking time. When a high concentration of oxidizing agent is used, the crosslinking reaction of the C-ALG solution with the oxidizing agent may also be uneven. For example, in the sample with a C-ALG concentration of 40 mg/mL and a NaIO4 /catechol molar ratio of 1, although its crosslinking time is short, in the case of a high NaIO4 /catechol molar ratio, due to the high reaction rate, its crosslinking forms an inhomogeneous hydrogel with particles.

交聯時間在2-5分鐘內的C-ALG水膠適合用於局部手術。若交聯時間太長或注入肺後無法交聯化,如此當患者在呼吸時C-ALG溶液仍會在肺內流動導致腫瘤定位不準確。而交聯時間也不能太短,否則C-ALG溶液在注射器中混合時就會難以透過注射針筒推擠施打。因此,根據胸腔外科醫師的建議,選擇在2-5分鐘內交聯的材料進行後續試驗,故選定CA-1、CA-2及CA-3進行後續試驗。C-ALG hydrogels with a crosslinking time within 2-5 minutes are suitable for topical surgery. If the cross-linking time is too long or cannot be cross-linked after being injected into the lung, the C-ALG solution will still flow in the lung when the patient breathes, resulting in inaccurate tumor localization. And the cross-linking time should not be too short, otherwise the C-ALG solution will be difficult to push and inject through the syringe when it is mixed in the syringe. Therefore, according to the advice of thoracic surgeons, materials that cross-link within 2-5 minutes were selected for follow-up tests, so CA-1, CA-2 and CA-3 were selected for follow-up tests.

實施例3─黏彈性測試Embodiment 3─viscoelasticity test

為了確定C-ALG水膠的機械性能,本實施例通過配備有直徑20mm平行板的流變儀來確定粘彈性,並通過底板將溫度控制在37℃,在掃頻模式下測量儲能模量(G')和損耗模量(G'')的變化,並記錄每個試驗組的最終條件和穩定性,其中完全交聯的水膠(預先在37°C下培養過夜)在測試之前製備成樣品(CA-1、CA-2和CA-3),並在頻率為0.1至1 Hz下操作,深度設定為10%,應變設定為1%。In order to determine the mechanical properties of the C-ALG hydrogel, this example determined the viscoelasticity by means of a rheometer equipped with a parallel plate with a diameter of 20 mm, and controlled the temperature at 37°C through the bottom plate, measured the changes in the storage modulus (G') and loss modulus (G'') in frequency sweep mode, and recorded the final conditions and stability of each test group, in which fully cross-linked hydrogels (incubated overnight at 37°C in advance) were prepared as samples (CA-1, CA-2 and CA-3) before testing, and Operate at a frequency of 0.1 to 1 Hz, with a depth setting of 10% and a strain setting of 1%.

如圖2所示,豬肺的(G')和損耗模量(G'')的值均高於CA-1、CA-2和CA-3,此外,CA-1、CA-2和CA-3的G'和G''值均與設定的頻率範圍無關,該頻率與正常呼吸頻率相似。這表明當將CA-1、CA-2和CA-3水膠植入體內肺組織時,它們的交聯網絡穩定且均一。與CA-1和CA-2相比,具有更高C-ALG和NaIO 4濃度的CA-3具有更高的G'值和更多的交聯網絡,並且更接近豬肺的G'。因此,CA-3水膠具有與豬肺相似的機械性能,並且比肺更柔軟,可以將CA-3水膠對周圍組織的不良影響降到最低。 As shown in Figure 2, the values of (G') and loss modulus (G'') of porcine lung were higher than those of CA-1, CA-2 and CA-3, and in addition, the values of G' and G'' of CA-1, CA-2 and CA-3 were independent of the set frequency range, which was similar to the normal breathing frequency. This indicates that the cross-linked networks of CA-1, CA-2, and CA-3 hydrogels are stable and uniform when they are implanted into lung tissue in vivo. Compared with CA-1 and CA-2, CA-3 with higher C-ALG and NaIO4 concentrations had higher G' value and more cross-linking network, and was closer to G' of porcine lung. Therefore, CA-3 hydrogel has similar mechanical properties to porcine lungs and is softer than lungs, which can minimize the adverse effects of CA-3 hydrogel on surrounding tissues.

實施例4─爆破壓力測試Example 4 - Burst Pressure Test

本實施例利用大鼠新鮮肺臟進行材料補肺漏氣前/後之壓力比較。將氣錶一端連接高壓空氣鋼瓶,另一端連接解剖下的大鼠肺臟之主氣管。當氣體灌入鼠肺使之處於膨脹的狀態下,用32-gauge針頭隨機在某一肺葉表面上造成1 mm深度的破洞,此時將破損處浸到生理食鹽水中,觀察氣泡冒出以確定肺漏氣,紀錄此時補肺漏氣之壓力值;將氣瓶關閉使肺舒張後,加入不同濃度之C-ALG水膠至肺破損處(使用固定量水膠約直徑0.7~0.8 mm、厚度1.0 mm)。經水膠填補肺破損處後再次灌入氣體,觀察是否仍有氣泡產生,並量測此時補肺後之壓力值 (bursting pressure)。In this example, fresh lungs of rats were used to compare the pressure before/after the material supplemented lung air leakage. Connect one end of the air gauge to a high-pressure air cylinder, and the other end to the main trachea of the dissected rat lung. When gas was poured into the mouse lung to make it inflated, a 32-gauge needle was used to randomly create a hole with a depth of 1 mm on the surface of a lung lobe. At this time, the damaged area was immersed in normal saline, and the air bubbles were observed to confirm the lung leak. After filling the damaged part of the lung with water glue, infuse air again, observe whether there are still air bubbles, and measure the pressure value (bursting pressure) after filling the lung at this time.

如圖3所示,在使用C-ALG水膠之前,大鼠肺缺損模型中的所有壓力均為190 mm-H 2O,而C-ALG水膠可將爆破壓力大幅提高至266 15 ~ 385 13 mm-H 2O。與CA-1相比,CA-3和CA-2能夠承受更高的壓力(p <0.05),但CA-3和CA-2兩者之間沒有顯著差異。本實施例顯示本申請所提供的水膠可以在局部手術後密封肺的注射孔來預防氣胸。 As shown in Figure 3, before using C-ALG hydrogel, all the pressures in the rat lung defect model were 190 mm-H 2 O, while C-ALG hydrogel could greatly increase the burst pressure to 266 15 ~ 385 13mm- H2O . CA-3 and CA-2 were able to withstand higher stress compared with CA-1 (p < 0.05), but there was no significant difference between CA-3 and CA-2. This example shows that the hydrogel provided by the present application can prevent pneumothorax by sealing the injection hole of the lung after local surgery.

實施例5─定位效果測試Example 5─Positioning effect test

本實施例使用傳統市場購買之豬肺進行測試,分別比較C-ALG水膠以及臨床使用的染劑Patent Blue V之定位效果。將 0.3 mL的C-ALG水膠及Patent Blue V分別滴到固定大小的豬肺表面上(長5 cm × 寬3 cm × 高0.5 cm),並將其浸泡於37℃的PBS中以模仿生物體內的生理環境。之後分別觀察0 h/1 h/ 2 h/ 4 h/ 8 h/ 24 h水膠固定於豬肺上的效果,並以Image J計算水膠材料及染劑的擴散面積。In this example, pig lungs purchased in the traditional market were used for testing, and the localization effects of C-ALG hydrogel and the clinically used dye Patent Blue V were compared. 0.3 mL of C-ALG hydrogel and Patent Blue V were dropped onto the surface of pig lungs of fixed size (length 5 cm × width 3 cm × height 0.5 cm), and soaked in PBS at 37 °C to simulate the physiological environment in vivo. Afterwards, the effects of 0 h/1 h/2 h/4 h/8 h/24 h of water gel fixation on pig lungs were observed respectively, and the diffusion area of water gel material and dye was calculated by Image J.

請參至圖4A,左側為C-ALG水膠,右側為Patent Blue V,交聯後C-ALG水膠的鋪展面積從2小時、8小時和24小時分別從0.575 ± 0.092 cm 2略微增加至0.728 ± 0.058 cm 2、0.8 ± 0.047 cm 2和0.818 ± 0.051 cm 2。相反,分別在2、8和24小時後,染劑Patent Blue V的深藍色之平均面積分別從1.594±0.878 cm 2廣泛增加至4.014±0.206 cm 2、6.401±1.274 cm 2和7.946±1.461 cm 2,請參照圖4B。 Please refer to Figure 4A, C-ALG hydrogel on the left and Patent Blue V on the right. After crosslinking, the spreading area of C-ALG hydrogel slightly increases from 0.575 ± 0.092 cm 2 to 0.728 ± 0.058 cm 2 , 0.8 ± 0.047 cm 2 and 0.818 ± 0.051 cm 2 in 2 hours, 8 hours and 24 hours respectively . On the contrary, after 2, 8 and 24 hours, the average area of the dark blue color of the dye Patent Blue V increased widely from 1.594±0.878 cm 2 to 4.014±0.206 cm 2 , 6.401±1.274 cm 2 and 7.946±1.461 cm 2 , respectively, please refer to Figure 4B.

此外,C-ALG水膠牢固地粘附在肺表面上,在局部化實驗中沒有移位。反之,染劑Patent Blue V幾乎遍布了整個肺部標本的1/2,並且肺表面上的藍色也褪色並變得模糊。顯示本申請提供的C-ALG水膠可有效且精準的定位手術患部。In addition, C-ALG hydrogel firmly adhered to the lung surface without displacement in localization experiments. On the contrary, the dye Patent Blue V spread almost 1/2 of the whole lung specimen, and the blue color on the surface of the lung also faded and became blurred. It shows that the C-ALG hydrogel provided by this application can effectively and accurately locate the affected part of the operation.

本實施例顯示用本申請提供的C-ALG水膠,其原本深褐色的呈色即可直接具有定位的功效,但實務上仍可視實際需求,添加不同的一般染劑、螢光染劑或顯影劑來加強其定位的功效。This example shows that the C-ALG water gel provided by this application can directly have the positioning effect due to its original dark brown color, but in practice, different general dyes, fluorescent dyes or developers can be added to enhance its positioning effect according to actual needs.

實施例6─兼具定位及修補功能之水膠套組的操作Example 6 - Operation of the water glue set with both positioning and repairing functions

本申請所提供的兼具定位及修補功能之水膠套組,其實務操作方式係在施用於患者前,將該鄰苯二酚–海藻酸鹽溶液、該氧化劑溶液及氧化氫酶快速且充分的混合,使之進行交聯反應而形成水膠,並在其完全成膠前、還尚有流動性的狀態下,注入患者欲手術切除之腫瘤患部作定位。由於鄰苯二酚–海藻酸鹽溶液和氧化劑溶液必須要快速且均勻的混合,以形成均質無顆粒的水膠,因此如圖5A所示,可將鄰苯二酚–海藻酸鹽溶液(111)置於一第一注射器(110)中,並將過碘酸鈉(121)置於一第二注射器(120)中,再將該第一注射器(110)與第二注射器(120)與一三向閥(130)中之任兩端連接,並關閉剩餘之一端,透過第一注射器(110)與第二注射器(120)交互施壓數次,以物理機械力使鄰苯二酚–海藻酸鹽溶液和氧化劑溶液可方便、快速且均勻的混合,最後形成鄰苯二酚–海藻酸鹽水膠(240),並將其全部推壓至第一注射器,如圖5B所示。接著,如圖5C所示,在準備將混合完成的鄰苯二酚–海藻酸鹽水膠注射至患者欲手術切除之腫瘤或惡性結節的患部時,可將三向閥轉換至關閉空的第二注射器之一端,並直接將針頭連接至該三向閥剩餘之一端,即可施用於患者。The practical operation method of the hydrogel set with both positioning and repairing functions provided by this application is to quickly and fully mix the catechol-alginate solution, the oxidizing agent solution, and catalase before applying it to the patient, so that it undergoes a cross-linking reaction to form a hydrogel, and before it is completely gelled and still has fluidity, it is injected into the patient's tumor to be surgically resected for positioning. Since the catechol-alginate solution and the oxidizing agent solution must be quickly and uniformly mixed to form a homogeneous particle-free water gel, as shown in Figure 5A, the catechol-alginate solution (111) can be placed in a first syringe (110), and sodium periodate (121) can be placed in a second syringe (120), and then the first syringe (110) and the second syringe (120) are connected to any two ends of a three-way valve (130). And close the remaining end, press alternately through the first syringe (110) and the second syringe (120) several times, use physical and mechanical force to make the catechol-alginate solution and the oxidant solution mix conveniently, quickly and uniformly, and finally form the catechol-alginate hydrogel (240), and push it all into the first syringe, as shown in Figure 5B. Next, as shown in Figure 5C, when the mixed catechol-alginate hydrogel is ready to be injected into the affected part of the patient's tumor or malignant nodule to be surgically removed, the three-way valve can be switched to close the empty end of the second syringe, and the needle can be directly connected to the remaining end of the three-way valve to be administered to the patient.

第一注射器與第二注射器可任意連接至三向閥的不同端,同時,混合完成的鄰苯二酚–海藻酸鹽水膠亦可選擇全部推至第一注射器或第二注射器。另外,在準備將混合完成的鄰苯二酚–海藻酸鹽水膠注射至患者欲手術切除之腫瘤患部時,亦可將含鄰苯二酚–海藻酸鹽水膠的注射器與三向閥分離,直接將針頭套上注射器來施用於患者。再者,可任意選擇雙向閥、四向閥等多向閥來進行鄰苯二酚–海藻酸鹽溶液和氧化劑溶液的混合。The first syringe and the second syringe can be connected to different ends of the three-way valve arbitrarily, and at the same time, the mixed catechol-alginate hydrogel can also be pushed to the first syringe or the second syringe. In addition, when preparing to inject the mixed catechol-alginate hydrogel into the tumor site of the patient to be surgically removed, the syringe containing the catechol-alginate hydrogel can also be separated from the three-way valve, and the needle can be directly put on the syringe to be administered to the patient. Furthermore, multi-way valves such as two-way valves and four-way valves can be arbitrarily selected to mix the catechol-alginate solution and the oxidizing agent solution.

100:兼具定位及修補功能之水膠套組 110:第一注射器 111:鄰苯二酚–海藻酸鹽溶液 120:第二注射器 121:氧化劑溶液 130:多向閥 200:兼具定位及修補功能之水膠套組 210:第一注射器 220:第二注射器 230:多向閥 240:鄰苯二酚–海藻酸鹽水膠 300:兼具定位及修補功能之水膠套組 310:第一注射器 320:第二注射器 330:多向閥 340:鄰苯二酚–海藻酸鹽水膠 350:針頭 100:Water glue set with both positioning and repair functions 110: The first syringe 111: Catechol – Alginate Solution 120: second syringe 121: oxidant solution 130: multi-way valve 200: Water glue set with positioning and repair functions 210: The first syringe 220:Second Syringe 230: multi-way valve 240: Catechol – Alginate Hydrogel 300: Water glue set with positioning and repair functions 310: first syringe 320: second syringe 330: multi-way valve 340: Catechol – Alginate Hydrogel 350: Needle

圖1顯示C-ALG溶液在交聯過程中的成色變化。Figure 1 shows the color change of C-ALG solution during the crosslinking process.

圖2顯示黏彈性測試的結果。Figure 2 shows the results of the viscoelasticity tests.

圖3顯示爆破壓力測試的結果。Figure 3 shows the results of the burst pressure test.

圖4A顯示定位效果測試的結果。Figure 4A shows the results of the localization effect test.

圖4B顯示圖4A之材料擴散面積經計算後之結果。FIG. 4B shows the calculated result of the diffusion area of the material in FIG. 4A .

圖5A顯示本申請之兼具定位及修補功能之水膠套組操作示意圖。FIG. 5A shows a schematic diagram of the operation of the hydrogel kit with positioning and repairing functions of the present application.

圖5B顯示本申請之兼具定位及修補功能之水膠套組操作示意圖。FIG. 5B shows a schematic diagram of the operation of the hydrogel kit with positioning and repairing functions of the present application.

圖5C顯示本申請之兼具定位及修補功能之水膠套組操作示意圖。FIG. 5C shows a schematic diagram of the operation of the hydrogel kit with positioning and repairing functions of the present application.

100:兼具定位及修補功能之水膠套組 100:Water glue set with both positioning and repair functions

110:第一注射器 110: The first syringe

111:鄰苯二酚-海藻酸鹽溶液 111: Catechol-alginate solution

120:第二注射器 120: second syringe

121:氧化劑溶液 121: oxidant solution

130:多向閥 130: multi-way valve

Claims (9)

一種兼具定位及修補功能之水膠套組,用於手術前的患部定位及修補,包含:鄰苯二酚-海藻酸鹽溶液,濃度35毫克/毫升(mg/mL)以上;氧化劑溶液,該氧化劑為過碘酸鹽;及過氧化氫酶;其中,該氧化劑與該鄰苯二酚-海藻酸鹽中鄰苯二酚基的莫耳比為0.1~2.2。 A hydrogel kit with both positioning and repairing functions, used for positioning and repairing affected parts before surgery, comprising: catechol-alginate solution with a concentration of 35 mg/ml (mg/mL) or more; an oxidizing agent solution, the oxidizing agent being periodate; and catalase; wherein the molar ratio of the oxidizing agent to the catechol group in the catechol-alginate is 0.1-2.2. 如請求項1之套組,其中該鄰苯二酚-海藻酸鹽溶液之濃度為35毫克/毫升(mg/mL)以上,該氧化劑與該鄰苯二酚-海藻酸鹽中鄰苯二酚基的莫耳比為0.2~0.8,該過氧化氫酶之濃度為600IU/mL~1000IU/mL。 The set of claim 1, wherein the concentration of the catechol-alginate solution is above 35 mg/mL, the molar ratio of the oxidant to the catechol group in the catechol-alginate is 0.2-0.8, and the concentration of the catalase is 600IU/mL-1000IU/mL. 如請求項1之套組,其中該鄰苯二酚-海藻酸鹽溶液之濃度為40毫克/毫升(mg/mL)以上,該氧化劑為過碘酸鈉,該氧化劑與該鄰苯二酚-海藻酸鹽中鄰苯二酚基的莫耳比為0.25~0.6,該過氧化氫酶之濃度為800IU/mL。 The set of claim 1, wherein the concentration of the catechol-alginate solution is above 40 mg/ml (mg/mL), the oxidizing agent is sodium periodate, the molar ratio of the oxidizing agent to the catechol group in the catechol-alginate is 0.25-0.6, and the concentration of the catalase is 800 IU/mL. 如請求項1之套組,其中更包含染劑、螢光染劑及/或顯影劑。 The set according to claim 1, further comprising a dye, a fluorescent dye and/or a developer. 如請求項1之套組,其中更包含:一第一注射器,包含該鄰苯二酚-海藻酸鹽溶液;一第二注射器,包含該氧化劑溶液;一多向閥;其中,該第一注射器包含該過氧化氫酶。 The kit according to claim 1, further comprising: a first syringe containing the catechol-alginate solution; a second syringe containing the oxidant solution; a multi-way valve; wherein the first syringe contains the catalase. 如請求項5之套組,其中該多向閥為雙向閥或三向閥。 The set of claim item 5, wherein the multi-way valve is a two-way valve or a three-way valve. 一種如請求項1之套組的用途,其係用於製備作為患部定位及修補的水膠。 A use of the set as claimed in claim 1, which is used to prepare water gel for positioning and repairing the affected part. 一種由請求項1之套組所製得之鄰苯二酚-海藻酸鹽水膠用於製備患部定位及修補水膠的用途。 A use of the catechol-alginate hydrogel prepared by the set of claim 1 for preparing the affected part positioning and repairing hydrogel. 如請求項1至6任一項之套組,該患部為肺中的腫瘤組織或惡性結節。 According to the set according to any one of claims 1 to 6, the affected part is tumor tissue or malignant nodule in the lung.
TW109144798A 2020-12-17 2020-12-17 Adhesive and localizing hydrogel kit and the use thereof TWI808364B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
TW109144798A TWI808364B (en) 2020-12-17 2020-12-17 Adhesive and localizing hydrogel kit and the use thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
TW109144798A TWI808364B (en) 2020-12-17 2020-12-17 Adhesive and localizing hydrogel kit and the use thereof

Publications (2)

Publication Number Publication Date
TW202228780A TW202228780A (en) 2022-08-01
TWI808364B true TWI808364B (en) 2023-07-11

Family

ID=83782750

Family Applications (1)

Application Number Title Priority Date Filing Date
TW109144798A TWI808364B (en) 2020-12-17 2020-12-17 Adhesive and localizing hydrogel kit and the use thereof

Country Status (1)

Country Link
TW (1) TWI808364B (en)

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
期刊 Seino Y, et al. "Application of a sodium alginate hydrogel for clear preoperative endoscopic marking using India ink" Polymer Journal 2020; 52:977-983. Published online:2020/4/22

Also Published As

Publication number Publication date
TW202228780A (en) 2022-08-01

Similar Documents

Publication Publication Date Title
Zhou et al. Injectable self‐healing natural biopolymer‐based hydrogel adhesive with thermoresponsive reversible adhesion for minimally invasive surgery
US8709480B2 (en) Adhering composition and method of applying the same
Xia et al. Adhesive hemostatic hydrogel with ultrafast gelation arrests acute upper gastrointestinal hemorrhage in pigs
Borden et al. Reversible electroadhesion of hydrogels to animal tissues for suture-less repair of cuts or tears
Park et al. Thermosensitive gallic acid-conjugated hexanoyl glycol chitosan as a novel wound healing biomaterial
CN110128682B (en) Sulfhydryl-aldehyde crosslinking hydrogel material and preparation method and application thereof
Muñoz Taboada et al. Sprayable hydrogel for instant sealing of vascular anastomosis
CN113336973A (en) Repair-promoting double-network hydrogel and preparation method and application thereof
CN108472405B (en) surgical sealant
CN107469135B (en) Heart sealing gel and preparation method thereof
CN105050630A (en) Adhesive medical products and methods for treating gastrointestinal lesions
CN106390185A (en) Preparation method of biological mimetic tissue adhesive
US11052171B2 (en) Method of hemostasis
US10335511B2 (en) Bioadhesive for occluding vessels
Gasek et al. Development of alginate and gelatin-based pleural and tracheal sealants
Ghovvati et al. Engineering a highly elastic bioadhesive for sealing soft and dynamic tissues
Xue et al. Adhesive cryogel particles for bridging confined and irregular tissue defects
CN113289052B (en) Controllable cross-linking and degradation material and application thereof
TWI808364B (en) Adhesive and localizing hydrogel kit and the use thereof
CN115515658A (en) Polymer material kit for hemostasis
CN116271188A (en) Medical hydrogel and its preparation method and its application in the preparation of vascular leakage sealant
CN118416289A (en) Absorbable sealing glue for anastomosis and preparation method and application thereof
CN118576750B (en) A biosynthetic injectable adhesive and its preparation method and application in intestinal fistula repair
KR102804571B1 (en) Water-based composition for body fluid leak detection
Annabi et al. Erratum for the Research Article:" Engineering a highly elastic human protein-based sealant for surgical applications" by N. Annabi, Y.-N. Zhang, A. Assmann, ES Sani, G. Cheng, AD Lassaletta, A. Vegh, B. Dehghani, GU Ruiz-Esparza, X. Wang, S. Gangadharan, AS Weiss, A. Khademhosseini.